The plasma giant’s share prices plummeted today as it released cuts to FY26 guidance, flagged more impairments and launched a broad simplification push.
The plasma giant’s share prices plummeted today as it released cuts to FY26 guidance, flagged more impairments and launched a broad simplification push.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.